Since I $ISRG (+1.9%) unfortunately ran out, I looked around for alternatives and came across the most important supplier. This is the $SUS (+2.19%) . I find it very interesting for the long-term part of my portfolio. Perhaps someone else has already looked into the company. Intuitive Surgical recently broke the sound barrier. For the first time, the global market leader for robot-assisted surgery is valued at over 200 billion dollars on the stock market. The US medtech giant's flagship product: the Da Vinci surgical systems. Robots have become indispensable in more and more operating theaters. However, Intuitive Surgical is also dependent on suppliers, for example for simulation software. Here, the Americans rely on the expertise of Surgical Science Sweden. The Scandinavians focus on medical simulation training and software solutions. Healthcare professionals can be taught and trained with the products from Surgical Science Sweden. Whether ultrasound, surgical procedures or routine examinations such as bronchoscopies or colonoscopies - the Swedes cover the entire range. In addition to Surgical Science Sweden's largest customer, robotics specialist Intuitive Surgical, its select clientele also includes medtech giants such as Abbott, Stryker, Boston Scientific and Medtronic. It was only in mid-January that the Swedish company intensified its collaboration with Intuitive Surgical with regard to the simulation software used in the Da Vinci systems. Together, they switched to a fully subscription-based revenue model until 2028. Full precision: The robotic arms of the Intuitive Surgical systems have become indispensable in many operating theaters. Surgical Science Sweden supplies the software for training. This increases the need for simulation software, which Surgical Science Sweden can supply. In recent years, the innovative medtech company has also grown through acquisitions. Just before Christmas, the management team led by CEO Tom Englund announced the acquisition of the British company Intelligent Ultrasound, a specialist in ultrasound simulation. The cost: 45.2 million British pounds (equivalent to 54.4 million euros). A clever move that not only expands Surgical Science Sweden's product portfolio, but also gives it direct access to the British market. Headquartered in Gothenburg, the company has already established local presences in the USA, Israel and China in addition to its headquarters in its home country. The decision-makers at Intelligent Ultrasound have approved the transaction, now the shareholders have to give the green light. Profitable growth Surgical Science Sweden has also seen a significant jump in sales and profits during the coronavirus pandemic thanks to the successful integration of SenseGraphics (2019) and Mimic and Simbionix (both 2021). In 2019, the Scandinavian company reported revenue of 101.5 million Swedish kronor (8.89 million euros) and a net profit of 12.6 million kronor (1.10 million euros). In 2023, Surgical Science Sweden earned a net profit of 234 million kronor (20.5 million euros) on sales of just under 883 million kronor (77.4 million euros). 2024 is likely to have been a year of transition, and growth at Surgical Science Sweden should pick up again from 2025. Analysts expect profits to double between 2023 and 2026, which would bring the P/E ratio down to an attractive 25 next year - with sales rising to just under 113 million euros. Growth opportunities in Asia The Asian market in particular offers considerable organic growth potential for Surgical Science Sweden. The company was recently selected by the Ministry of Defense of a Southeast Asian country to supply 30 units of its TraumaVR simulator. This will be used to train the country's military medical personnel. Value: around 4.5 million euros. - Top position in the niche Surgical Science Sweden operates in a fast-growing market with manageable competition. The company is already benefiting from the success of Intuitive Surgical's surgical robots. The company's share is also in bullish shape again on the chart.
